Gram-Negative Antibiotic Coverage in Gustilo-Anderson Type-III Open Fractures

Thomas L Hand¹, Elizabeth O Hand^{1

2}, Amber Welborn¹, Boris A Zelle¹

Affiliations

¹ Department of Orthopaedics (T.L.H. and B.A.Z.) and the Pharmacotherapy Education and Research Center (E.O.H. and A.W.), UT Health San Antonio, San Antonio, Texas.
² Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, Texas.

Review

Thomas L Hand et al. J Bone Joint Surg Am. 2020.

. 2020 Aug 19;102(16):1468-1474.

doi: 10.2106/JBJS.19.01358.

Thomas L Hand¹, Elizabeth O Hand^{1

2}, Amber Welborn¹, Boris A Zelle¹

¹ Department of Orthopaedics (T.L.H. and B.A.Z.) and the Pharmacotherapy Education and Research Center (E.O.H. and A.W.), UT Health San Antonio, San Antonio, Texas.
² Department of Pharmacotherapy and Pharmacy Services, University Health System, San Antonio, Texas.

No abstract available

References

1. Gustilo RB, Merkow RL, Templeman D. The management of open fractures. J Bone Joint Surg Am. 1990 Feb;72(2):299-304.
1. Okike K, Bhattacharyya T. Trends in the management of open fractures. A critical analysis. J Bone Joint Surg Am. 2006 Dec;88(12):2739-48.
1. Patzakis MJ, Wilkins J, Moore TM. Considerations in reducing the infection rate in open tibial fractures. Clin Orthop Relat Res. 1983 Sep;178:36-41.
1. Gustilo RB, Anderson JT. Prevention of infection in the treatment of one thousand and twenty-five open fractures of long bones: retrospective and prospective analyses. J Bone Joint Surg Am. 1976 Jun;58(4):453-8.
1. Elniel AR, Giannoudis PV. Open fractures of the lower extremity: current management and clinical outcomes. EFORT Open Rev. 2018 May 21;3(5):316-25.